NAD(+) and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents

Autor Harkcom, William T., Ghosh, Ananda K., Sung, Matthew S., Matov, Alexandre, Brown, Kevin D., Giannakakou, Paraskevi, Jaffrey, Samie R.
Vydáno 2014

Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device

Autor Galletti, Giuseppe, Sung, Matthew S., Vahdat, Linda T., Shah, Manish A., Santana, Steven M., Altavilla, Giuseppe, Kirby, Brian J., Giannakakou, Paraskevi
Vydáno 2013

Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer

Autor Thadani-Mulero, Maria, Portella, Luigi, Sun, Shihua, Sung, Matthew, Matov, Alexandre, Vessella, Robert L., Corey, Eva, Nanus, David M., Plymate, Stephen R., Giannakakou, Paraskevi
Vydáno 2014

Use of translational modeling and simulation for quantitative comparison of PF-06804103, a new generation HER2 ADC, with Trastuzumab-DM1

Autor Betts, Alison, Clark, Tracey, Jasper, Paul, Tolsma, John, van der Graaf, Piet H., Graziani, Edmund I., Rosfjord, Edward, Sung, Matthew, Ma, Dangshe, Barletta, Frank
Vydáno v J Pharmacokinet Pharmacodyn (2020)

Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia

Autor Zhang, Cathy C, Yan, Zhengming, Pascual, Bernadette, Jackson-Fisher, Amy, Huang, Donghui Stephen, Zong, Qing, Elliott, Mark, Fan, Conglin, Huser, Nanni, Lee, Joseph, Sung, Matthew, Sapra, Puja
Vydáno v Neoplasia (2017)

ERG induces taxane resistance in castration-resistant prostate cancer

Autor Galletti, Giuseppe, Matov, Alexandre, Beltran, Himisha, Fontugne, Jacqueline, Miguel Mosquera, Juan, Cheung, Cynthia, MacDonald, Theresa Y., Sung, Matthew, O’Toole, Sandra, Kench, James G., Suk Chae, Sung, Kimovski, Dragi, Tagawa, Scott T., Nanus, David M., Rubin, Mark A., Horvath, Lisa G., Giannakakou, Paraskevi, Rickman, David S.
Vydáno v Nat Commun (2014)